Bone tissue in rheumatoid arthritis (2). Pathophysiologic data, pathologic findings, and therapeutic implications.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Revue du rhumatisme

• Publication date

  1995-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 7788338
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Osteocalcin in patients with rheumatoid arthritis — effect of anatomical stages, inflammatory activity and therapy

  2004cited by this paper
• Methotrexate osteopathy

  2004cited by this paper
• Double blind radiological assessment of continuous oral pamidronic acid in patients with rheumatoid arthritis.

  1994cited by this paper
• Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis.

  1994cited by this paper
• Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study.

  1994cited by this paper
• Generalised bone loss in patients with early rheumatoid arthritis.

  1994cited by this paper
• Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis.

  1994cited by this paper
• A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis.

  1994cited by this paper
• Longitudinal bone mineral density changes in early rheumatoid arthritis.

  1994cited by this paper
• Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis. Effects of low-dose corticosteroids.

  1993cited by this paper
• Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation.

  1993cited by this paper
• Bone metabolism in rheumatoid arthritis; relation to disease activity.

  1993cited by this paper
• The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women.

  1993cited by this paper
• Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry

  1993cited by this paper
• Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis.

  1993cited by this paper
• Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis.

  1993cited by this paper
• Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity.

  1993cited by this paper
• Methotrexate osteopathy in rheumatic disease.

  1993cited by this paper
• Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis.

  1993cited by this paper
• Serum osteocalcin and calcitropic hormones in a homogeneous group of patients with rheumatoid arthritis: its implication in the osteopenia of the disease.

  1993cited by this paper
• Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis.

  1993cited by this paper
• Physical activity as a determinant of bone conservation in the radial diaphysis in rheumatoid arthritis.

  1993cited by this paper
• Bone mineral density in ambulant, non-steroid treated female patients with rheumatoid arthritis.

  1993cited by this paper
• Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy.

  1992cited by this paper
• Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens.

  1992cited by this paper
• Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.

  1992cited by this paper
• Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.

  1992cited by this paper
• Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.

  1992cited by this paper
• Bone mineral content in patients with rheumatoid arthritis: relationship to low-dose steroid therapy.

  1991cited by this paper
• Can exercise prevent osteoporosis?

  1991cited by this paper
• Abnormal osteocalcin binding in rheumatoid arthritis.

  1990cited by this paper
• Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

  1990cited by this paper
• Osteopenia in rheumatoid arthritis: a biochemical, hormonal and histomorphometric study

  1990cited by this paper
• Axial bone density in rheumatoid arthritis: comparison of dual-energy projection radiography and dual-photon absorptiometry.

  1989cited by this paper
• Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis.

  1989cited by this paper
• Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis.

  1989cited by this paper
• Bone GLA protein (BGP) levels and bone turnover in rheumatoid arthritis.

  1989cited by this paper
• Inflammatory cell changes in haversian canals. A possible cause of osteoporosis in rheumatoid arthritis.

  1989cited by this paper
• Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases.

  1989cited by this paper
• Serum osteocalcin concentrations in patients with rheumatoid arthritis.

  1989cited by this paper
• Serum osteocalcin (bone Gla-protein) following corticosteroid therapy in postmenopausal women with rheumatoid arthritis. Comparison of the effect of prednisone and deflazacort

  1988cited by this paper
• Spinal trabecular bone mineral content in patients with non-steroid treated rheumatoid arthritis.

  1988cited by this paper
• Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis.

  1987cited by this paper
• Procollagen type I carboxy‐terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase

  1987cited by this paper
• Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis.

  1987cited by this paper
• Determinants of axial bone loss in rheumatoid arthritis.

  1987cited by this paper
• Comparison of the effects of auranofin, gold sodium thiomalate, and penicillamine on resorption of cultured fetal rat long bones

  1987cited by this paper
• Measures of bone loss in rheumatoid arthritis.

  1986cited by this paper
• Bone metabolism in rheumatoid arthritis compared with postmenopausal osteoporosis.

  1986cited by this paper
• Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids.

  1986cited by this paper
• Increased levels of osteocalcin (serum bone Gla-protein) in rheumatoid arthritis.

  1986cited by this paper
• Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids.

  1986cited by this paper
• Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis?

  1985cited by this paper
• The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Influence of menopausal state.

  1985cited by this paper
• Bone turnover in early rheumatoid arthritis. 2. Longitudinal bone density studies.

  1985cited by this paper
• Bone turnover in early rheumatoid arthritis. 1. Biochemical and kinetic indexes.

  1985cited by this paper
• Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases.

  1985cited by this paper
• Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans

  1984cited by this paper
• The effect of low dosage glucocorticoids on bone mass in rheumatoid arthritis: a cross-sectional and a longitudinal study using single photon absorptiometry.

  1984cited by this paper
• Increased bone metabolism in rheumatoid arthritis as measured by the whole-body retention of 99Tcm methylene diphosphonate.

  1983cited by this paper
• Glucocorticoid-induced osteoporosis.

  1983cited by this paper
• Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment.

  1982cited by this paper
• Inhibitory effect on bone formation and calcification exerted by the anti-inflammatory drug ibuprofen. An experimental study on adult rat with fracture.

  1981cited by this paper
• Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy.

  1981cited by this paper
• Synovial fluid and serum hydroxyproline fractions in rheumatoid arthritis.

  1979cited by this paper

• Factors influencing bone loss in rheumatoid arthritis: a longitudinal study.

  2000cites this paper
• Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.

  1999cites this paper
• Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.

  1997cites this paper
• How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.

  1997cites this paper
• Perimenopausal and postmenopausal hormone replacement therapy. Part 1. An update of the literature on benefits and risks.

  1996cites this paper